PharmaCyte Biotech (PMCB) Inventory Average (2011 - 2012)
PharmaCyte Biotech (PMCB) posted quarterly Inventory Average of $8233.0 for Q3 2012, down 37.45% year-over-year from $13161.5 in Q3 2011, and up 79.9% quarter-over-quarter from $4576.5 in Q2 2012.
PharmaCyte Biotech (PMCB) Inventory Average (2011 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Inventory Average for 2 consecutive years, with $8233.0 the latest figure, recorded in Q3 2012.
- In Q3 2012, Inventory Average fell 37.45% year-over-year to $8233.0; the TTM figure through Jul 2012 stood at $8233.0 (down 37.45% YoY), while the FY2012 annual figure was $12776.0, changed N/A from the prior year.
- Inventory Average climbed to $8233.0 in Q3 2012 per PMCB's latest filing, from $4576.5 in the prior quarter.
- Across five years, Inventory Average topped out at $13161.5 in Q3 2011 and bottomed at $3412.5 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | PharmaCyte Biotech | 4.30 Mn | 4.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2012 | 8,233.00 |
| Apr 30, 2012 | 4,576.50 |
| Jan 31, 2012 | 3,412.50 |
| Oct 31, 2011 | 6,067.50 |
| Jul 31, 2011 | 13,161.50 |